Published online Sep 9, 2025. doi: 10.5409/wjcp.v14.i3.100306
Revised: February 15, 2025
Accepted: April 2, 2025
Published online: September 9, 2025
Processing time: 307 Days and 2 Hours
Overweight children exhibit a higher prevalence of functional gastrointestinal disorders compared with their normal-weight peers, yet the underlying reasons remain unclear. Gastrointestinal motility, a key pathophysiological factor in functional gastrointestinal disorders, may be influenced by body mass index (BMI).
To evaluate the impact of BMI on gastric motility parameters in children with functional abdominal pain disorders (FAPDs).
We assessed gastric motility in 176 children with FAPDs (61.4% females, mean age 7.94 years, SD 1.96 years) and 63 healthy controls (57.1% females, mean age 9.17 years, SD 1.90 years) at the Gastroenterology Research Laboratory, University of Kelaniya, Sri Lanka. FAPDs were diagnosed and subtyped using the Rome IV criteria: Functional abdominal pain 97 patients; irritable bowel syndrome 39 patients, functional dyspepsia (FD) 25 patients; and abdominal migraine 15 patients. Gastric motility was measured using a validated ultrasound method. Weight and height were measured using sensitive standard scales.
The BMIs of children with FAPDs and controls were 15.04 and 15.46 kg/m², respectively (P = 0.33). Fasting antral area (FAA) and antral area at 1 min (AA1) and 15 min (AA15) were significantly greater in patients with FAPD with a higher BMI (2.71 cm², 12.57 cm², and 7.19 cm², respectively) compared with those with a lower BMI (2.12 cm², 10.68 cm², and 6.13 cm², respectively) (P < 0.01). BMI positively correlated with FAA and AA15 (r = 0.18 and r = 0.19, respectively) (P < 0.01) in those with FAPDs. In controls, only AA1 was greater in the higher BMI group (12.51 cm² vs 9.93 cm²) and had a positive correlation (r = 0.33) (P ≤ 0.01). Subgroup analysis revealed that in patients with FD, BMI negatively correlated with gastric emptying rate (GER) (r = -0.59) and antral motility index (MI) (r = -0.49), while in functional abdominal pain, MI positively correlated (r = 0.25) with BMI (P ≤ 0.01).
In children with FAPDs, higher BMI was associated with increased gastric antral distention during fasting and postprandial periods (as indicated by FAA, AA1, and AA15) but not with contractility and transit (MI, GER). However, in the FD subgroup, high BMI correlated with reduced GER and MI. This indicates the possible role of BMI in gastric hypomotility and the pathophysiology of FD. These findings underscore the importance of lifestyle and dietary interventions aimed at optimizing BMI in the management of FAPDs, particularly FD.
Core Tip: This study investigated the relationship between body mass index (BMI) and gastric motility in children with functional abdominal pain disorders (FAPDs). When considering FAPDs in general, higher BMI is associated with increased gastric antral distention but does not affect gastric contractility or transit. However, in the subgroup of children with functional dyspepsia, a higher BMI correlates with reduced gastric emptying rate and motility index, suggesting a role for BMI in gastric hypomotility. These findings offer new insights into how BMI influences gastrointestinal function in pediatric FAPDs, particularly in functional dyspepsia.
- Citation: Karunanayake A, Rajindrajith S, Kumari MV, Devanarayana NM. Effects of body mass index on gastric motility: Comparing children with functional abdominal pain disorders and healthy controls. World J Clin Pediatr 2025; 14(3): 100306
- URL: https://www.wjgnet.com/2219-2808/full/v14/i3/100306.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v14.i3.100306
Both increased body weight (overweight and obesity) and functional abdominal pain disorders (FAPDs) are significant health problems among school-aged children worldwide, causing significant morbidity, poor quality of life, and high healthcare costs[1-3].
According to the World Health Organization (WHO), obesity is defined as body mass index (BMI) > 2 standard deviations (SD) above the WHO growth standard median and overweight as BMI > 1 SD above the WHO growth standard median[4]. It was reported that the overall prevalence of pediatric obesity, overweight, and excess weight is 8.5%, 14.8%, and 22.2%, respectively[3]. A higher prevalence of obesity among children and adolescents was reported in countries with Human Development Index scores of 0.8 or greater and high-income countries or regions compared with developing countries[3]. However, the prevalence of obesity and overweight is rapidly increasing in developing countries, too. The prevalence of obesity and overweight was reported to be 10.3% and 11.3%, respectively, among 5-18-year-olds in urban Sri Lanka[5].
Functional gastrointestinal disorders (FGIDs) are defined as chronic or recurrent gastrointestinal symptoms not explained by structural or biochemical abnormalities and are categorized into subtypes using the Rome IV criteria[6]. Irritable bowel syndrome (IBS), functional dyspepsia (FD), functional abdominal pain (FAP), and abdominal migraine (AM) are among the common FGIDs in children[7]. The global prevalence of FAPDs is estimated to be 13.5%[1]. In Sri Lanka, the prevalence of FAPDs is 12.5%[8].
The pathophysiology of FGIDs is a grey area in gastroenterology. Even with modern technologies, the patho
Previous studies have shown a relationship between increased BMI and FGIDs. In one study, 50% of children who are overweight had at least one FGID[26]. Furthermore, obesity is reported to be associated with multiple FGIDs[27]. In addition, a long-term follow-up study conducted on children with FGIDs has shown that obesity is associated with poor outcomes and disability[28].
Several studies have demonstrated the complex indirect relationship between gastrointestinal motility and BMI abnormalities. Some peptides and hormones secreted in response to overeating, gastric distension, and high-body fat content (e.g., leptin, insulin-like growth factor 1, peptide YY, cholecystokinin, glucagon-like peptide 1, glucose-dependent insulinotropic peptide, oxyntomodulin) are shown to reduce gastrointestinal motility. In addition, frequent food intake is associated with a reduction in gastrointestinal motility-inducing hormones secreted during the fasting period (e.g., ghrelin, motilin), and this may contribute to reduced gastrointestinal motility[29-32].
A poorly understood pathophysiology is the main barrier to the management of FGIDs[33]. With increased urbanization, changes in dietary habits, and sedentary lifestyles, childhood obesity and overweight are becoming a global burden in both developed and developing countries around the globe. The main objective of this study was to assess the effects of BMI on gastric motility parameters in children with FAPDs.
This was a comparative, cross-sectional study.
Children aged 5 to 12 years with FAPDs who met the inclusion criteria were consecutively recruited from the pediatric clinics at the North Colombo Teaching Hospital in Ragama, Sri Lanka. They were then assessed at the Gastroenterology Research Laboratory, Faculty of Medicine, University of Kelaniya, Sri Lanka. A comprehensive history was obtained from each child and their parents, after securing written informed consent. The diagnosis of FAPDs was made according to the Rome IV criteria[6].
(1) Fulfill Rome IV criteria for at least one FAPD; and (2) Abdominal pain is severe enough to interrupt the activities of the child (e.g., sleep, play, schooling, etc.).
(1) Clinical or laboratory evidence suggesting organic pathology; (2) Chronic medical or surgical disease other than FAPDs; (3) Long-term medication for any illness other than FAPDs; and (4) Previous abdominal surgery.
All patients underwent a thorough screening for organic diseases. It included a detailed medical history, comprehensive physical examination (including assessment of growth parameters), stool and urine microscopy, urine culture, complete blood count, C-reactive protein, liver and renal function tests, and an abdominal ultrasound scan. Additional investigations, including upper and lower gastrointestinal endoscopy, serum amylase levels, and X-rays of the kidneys, ureters, and bladder, were performed when deemed necessary by the consultant pediatrician. Screening for celiac disease was not conducted due to its exceptional rarity in Sri Lanka.
An age-matched and sex-matched group of healthy children from the same geographical area was recruited as controls after obtaining parental consent. None of the controls exhibited any acute or chronic gastrointestinal symptoms, FGIDs, or signs of other acute or chronic diseases.
Assessment of gastric motility: Gastric motility was evaluated between 8:30 am and 9:30 am under thermoneutral conditions (26 °C). Females who had reached menarche underwent laboratory testing during the proliferative phase of their menstrual cycle. Any medications with prokinetic, adrenergic, or cholinergic properties were discontinued for a period of at least five times the half-life of the medication. Participants were instructed to avoid caffeine, nicotine, and alcohol-containing beverages for at least 8 h before testing.
Gastric motility was assessed in all subjects after a 6-h fast, using a validated ultrasound method previously reported in the literature[34]. A high-resolution real-time scanner (Siemens ACUSON X300™) equipped with 1.8 MHz to 6.4 MHz curved linear transducers, which allowed for recording and playback, was used for all measurements. After consuming a standard liquid meal heated to approximately 40 °C (200 mL of chicken broth, 54.8 kJ, 0.38 g protein, 0.25 g fat, 2.3 g sugar per serving, Ajinomoto Co., Tokyo, Japan) within 2 min, the subjects were seated in a chair leaning slightly backwards for the ultrasound examination. To eliminate inter-observer variability, all ultrasound measurements were conducted by the same investigator.
The primary gastric motility parameters evaluated and calculated included fasting antral area (FAA), antral area at 1 minute (AA1) and 15 minutes (AA15) post-meal, frequency of antral contractions, amplitude of antral contraction (AAC), antral motility index (MI), and GER[34].
Anthropometric measurements: The height and weight were measured by a trained investigator on participants who wore minimal clothing and were barefoot. Body weight was measured to the nearest 0.01 kg using a highly sensitive digital weighing scale. Body height was determined to the nearest 1 mm using a standard stadiometer. BMI was calculated as body weight (kg)/body height (m2).
Study participants were categorized into two groups according to BMI based on Sri Lankan normal values: Lower BMI (BMI < 15 kg/m2), and Higher BMI (BMI ≥ 15 kg/m2).
At 80% power (1 - β = 0.80) and a 5% significance level (α = 0.05), the minimum sample required for this case-control study was 78 per group. Using a case-to-control ratio of approximately 2.8: 1, 176 patients with FAPDs and 63 controls were recruited.
Statistical analyses were conducted using PSPP version 2.0.1 (Free Software Foundation, Inc., http://fsf.org/). Continuous variables were expressed as mean ± SD, while categorical variables were presented as proportions. Differences in continuous variables were assessed using the independent samples t-test. The Pearson correlation coefficient (r) was used to measure a linear correlation between two variables. A two-tailed P value of less than 0.05 was considered statistically significant.
This study protocol was approved by the Ethics Review Committee, Faculty of Medicine, University of Kelaniya, Sri Lanka. Written informed consent was obtained from a parent or a legal guardian of the children recruited.
One hundred seventy-six patients with FAPDs were recruited for this study [108 (61.4%) females, mean age 8.06 years (SD 1.99 years)]. There were 97 patients with FAP, 39 patients with IBS, 25 patients with FD, and 15 patients with AM. The mean BMI of the females was 15.00 (SD 3.10) kg/m2, and for males was 15.10 (SD 2.50) kg/m2. According to the WHO definition[4], only 21 (11.9%) children with FAPDs were overweight, and none fulfilled the criteria for obesity.
Sixty-three healthy controls were recruited [36 (57.1%) females, mean age 8.97 years (SD 1.90 years)]. In the control group, the BMI of the females was 16.19 (SD 3.40) kg/m2, and for the males was 14.49 (SD 2.30) kg/m2.
There were 140 children with lower BMI (< 15 kg/m2) and 99 with higher BMI (≥ 15 kg/m2). Table 1 compares the gastric motility parameters between lower BMI and higher BMI in patients with FAPDs and controls. FAA, AA1, and AA15 were significantly larger in patients with higher BMI than in those with lower BMI. In the control group, only AA1 was significantly larger in children with a higher BMI.
Motility parameter | FAPDs | Controls | ||||
BMI < 15 kg/m2 (n = 109) | BMI ≥ 15 kg/m2 (n = 67) | P value1 | BMI < 15 kg/m2 (n = 31) | BMI ≥ 15 kg/m2 (n = 32) | P value1 | |
Fasting antral area (cm2) | 2.12 | 2.71 | 0.008 | 1.65 | 2.16 | 0.058 |
Antral area in 1 min (cm2) | 10.68 | 12.57 | 0.004 | 9.93 | 12.61 | 0.001 |
Antral area in 15 min (cm2) | 6.13 | 7.19 | 0.009 | 4.03 | 4.95 | 0.088 |
Gastric emptying rate (%) | 43.01 | 40.26 | 0.240 | 59.64 | 59.37 | 0.947 |
Frequency of antral contraction (3 min) | 8.52 | 8.48 | 0.809 | 9.61 | 9.33 | 0.152 |
Amplitude of antral contraction (%) | 43.21 | 46.28 | 0.117 | 61.93 | 61.25 | 0.868 |
Antral motility index | 3.68 | 3.98 | 0.125 | 5.83 | 5.78 | 0.903 |
Table 2 describes the correlation between different gastric motility parameters and BMI in patients with FAPDs and controls. The only gastric mobility parameters that correlated with BMI were FAA and AA1 in the FAPD group and AA1 in the controls.
Motility parameter | FAPDs (n = 176) | Controls (n = 63) | ||
r | P value | r | P value | |
Fasting antral area | 0.183 | 0.015 | 0.234 | 0.065 |
Antral area at 1 min | 0.143 | 0.059 | 0.332 | 0.008 |
Antral area at 15 min | 0.190 | 0.011 | 0.227 | 0.074 |
Gastric emptying rate | -0.137 | 0.071 | -0.049 | 0.704 |
Frequency of antral contractions | 0.014 | 0.858 | -0.208 | 0.103 |
Amplitude of antral contractions | 0.130 | 0.086 | -0.016 | 0.900 |
Antral motility index | 0.132 | 0.081 | -0.076 | 0.552 |
When subgroup analysis was performed (Table 3), the patients with FD, FAA, and AA15 had significant positive correlations with BMI, while GER, AAC, and MI had significant negative correlations. In the FAP subgroup, AAC and MI had positive correlations with BMI. The AM subgroup had shown a significant positive correlation between AA1 and BMI. The IBS group had no significant correlation between BMI and motility parameters.
Motility parameter | IBS (n = 39) | FAP (n = 97) | FD (n = 25) | AM (n = 15) | ||||
r | P value | r | P value | r | P value | r | P value | |
Fasting antral area | 0.177 | 0.280 | 0.011 | 0.915 | 0.446 | 0.025 | 0.513 | 0.050 |
Antral area at 1 min | 0.136 | 0.410 | 0.062 | 0.545 | 0.304 | 0.140 | 0.564 | 0.028 |
Antral area at 15 min | 0.115 | 0.486 | 0.083 | 0.420 | 0.642 | 0.001 | 0.351 | 0.199 |
Gastric emptying rate | 0.027 | 0.873 | -0.082 | 0.427 | -0.592 | 0.002 | 0.065 | 0.819 |
Frequency of antral contractions | 0.137 | 0.404 | 0.040 | 0.698 | -0.284 | 0.170 | -0.172 | 0.539 |
Amplitude of antral contractions | 0.144 | 0.381 | 0.263 | 0.009 | -0.510 | 0.009 | 0.160 | 0.568 |
Antral motility index | 0.204 | 0.213 | 0.254 | 0.012 | -0.489 | 0.013 | 0.003 | 0.992 |
To our knowledge, this is the first study to explore the relationship between BMI and gastric motility in children with FAPDs. In our cohort with FAPDs, those with higher BMI (≥ 15 kg/m2) exhibited significantly greater gastric distension during fasting (FAA) and postprandial periods (AA1 and AA15) compared to their peers with lower BMI (< 15 kg/m2). However, other key motility parameters, such as GER and antral MI, did not differ significantly between BMI groups. When examining the correlation between BMI and gastric motility in children with FAPDs, we found a positive relationship with FAA and AA1 but not with GER and antral MI.
However, when analyzing different FAPD subtypes, a distinct pattern emerged. In children with FD, BMI negatively correlated with key motility parameters, including GER and antral MI, in addition to parameters indicating gastric distension. Conversely, in children with FAP, we observed a weak but positive correlation between BMI and antral MI.
It is suggested that a higher BMI can influence gastric motility, potentially leading to delayed gastric emptying and other motility disturbances[35]. In contrast to this, when analyzing FAPDs in general, we did not observe the differences in gastric emptying and antral MI with high BMI. However, in the patients with FAPDs, the gastric motility parameters indicating increased gastric antral distension were significantly higher in those with a high BMI. Similarly, when we assessed the correlation between BMI and gastric motility parameters, weak but positive correlations were found between BMI and FAA and AA15 after the test meal in the FAPD group and AA1 in controls. This pattern suggests that a higher BMI may contribute to more pronounced distension of the stomach during the fasting and postprandial periods in patients with FAPDs. This likely contributes to the development and/or aggravation of symptoms.
However, the subgroup analysis revealed that the relationship between BMI and gastric motility parameters varies across different FAPD subtypes. In children with FD, both FAA and AA15 were positively correlated with BMI, while GER, AAC, and MI were negatively correlated. This pattern suggests that in FD, in addition to increased distension of gastric antrum, a significant motility hypofunction is also present during both fasting and postprandial periods. This probably contributes to the symptoms such as early satiety, bloating, nausea, distension, and vomiting present in children with FD in addition to the epigastric pain[23,36,37].
The AM subgroup also exhibited a significant positive correlation between BMI and AA1 (which is an indirect indicator of gastric distension after a meal), suggesting that BMI might play some role in the pathophysiology of AM, especially causing symptoms such as nausea and vomiting. However, this association is less understood and requires additional research.
The absence of a significant correlation between BMI and motility parameters in the IBS subgroup could indicate that BMI has a less direct impact on gastric motility in IBS, which is primarily characterized by altered bowel habits than gastric dysmotility[21].
In contrast, in the FAP subgroup, BMI had weak but positive correlations with AAC and MI, indicating that a higher BMI might be associated with gastric hypermotility. This is a novel finding that warrants further investigation as it contrasts with the typically hypoactive motility patterns reported to be associated with high BMI in FGIDs[30].
The underlying pathophysiology for gastric antral distension and impaired gastric motility associated with higher BMI in our children with FAPDs, especially FD, needs further evaluation. The autonomic nervous system is considered one of the main regulators of gastrointestinal function including motility. Previous studies have suggested that functional extrinsic denervation and maladaptation in the parasympathetic division could partly contribute to the gastric dysmotility observed in children with FAPDs[20]. Although studies do not permit solid inferences regarding sympathetic activity in pediatric subjects who are obese, they do indicate lower vagal activity in children and adolescents who are obese compared with their normal-weight counterparts[38]. Dysfunction of the autonomic nervous system associated with high BMI is one possible underlying pathophysiological mechanism for the relationship between gastric motility dysfunction and high BMI in our patients with FD[39,40].
Furthermore, various hormones play a crucial role in modulating gastric motility, especially in individuals who are obese. The reduced levels of ghrelin, a hormone known to stimulate gastric motility, are often observed in subjects who are obese, leading to impaired gastric function and motility[29]. Cortisol, another key hormone, inhibits gastric motor function in the antrum and corpus through CRF-2 receptors[30]. Neuropeptide Y, a neurotransmitter secreted by visceral fat tissue promotes food intake and fat storage and inhibits gastric motility through its receptors found in the stomach[32]. Additionally, obesity is associated with increased endocannabinoid production in hypertrophic adipose tissue and the brain, which by acting on CB1 receptors stimulates appetite and perpetuates a cycle of weight gain. The activation of these receptors also delays gastric emptying and increases gastric acid secretion, further contributing to the motility disorders seen in obesity[31].
In addition, there is a direct relationship between energy intake, storage, expenditure, and gastrointestinal functions. The sensory and motor functions of the stomach, including gastric emptying and accommodation, play a crucial role in regulating energy consumption and appetite. Obesity, which is marked by an energy imbalance, often involves altered gastric functions. In particular, rapid gastric emptying and an increased fasting gastric volume in individuals who are obese can lead to greater food intake before reaching the sensation of fullness and heightened appetite[41]. Patients with FGIDs, including FD, usually have a hypersensitive gastrointestinal tract, and they probably have an exaggerated response, giving rise to this negative correlation[42].
These findings have important clinical implications for the management of FAPDs in children. The significant correlations between BMI and gastric motility parameters, particularly in FD, suggest that weight management could be a crucial component of therapeutic strategies for this condition. Interventions aimed at achieving a healthy BMI might help normalize gastric motility and reduce symptoms, especially in children with FD where a higher BMI is associated with more severe motility dysfunction. We used Sri Lankan BMI normal values to categorize children into different subgroups instead of international cutoffs. It is based on evidence that BMI cutoff values for overweight and obesity may not correspond to the same degree of fat content across different populations. The WHO technical report explicitly recognizes the need for population-specific rather than universal BMI cutoff values as ethnicity significantly influences body composition[4].
While the study provides valuable insights, it is important to acknowledge its limitations. The cross-sectional design limits the ability to infer causality between BMI and gastric motility abnormalities. Longitudinal studies are needed to determine whether changes in BMI over time directly influence the progression of gastric motility dysfunction in children with FAPDs. Additionally, the relatively small sample size in certain FAPD subgroups, particularly in AM, may limit the generalizability of the findings. Future research should aim to replicate these results in larger, more diverse cohorts to confirm the observed associations and explore the underlying mechanisms. Furthermore, the study focused solely on gastric motility, but other aspects of gastrointestinal function, such as intestinal transit and gut-brain axis interactions, may also be influenced by BMI and contribute to the symptoms of FAPDs. At the same time, other factors, such as dietary habits and psychological influences, may contribute to the observed gastric motility changes in children with FAPDs. These factors could modulate gastrointestinal function through mechanisms such as gut-brain axis interactions, stress-related hormonal changes, and altered feeding behaviors. Integrating assessments of these factors in future studies could provide a more comprehensive understanding of the relationship between BMI, gastrointestinal motility, and FGIDs in children.
Our study identified a significant relationship between elevated BMI and altered gastric motility dynamics characterized by increased gastric distension during both fasting (FAA) and postprandial (AA1, AA15) periods. Additionally, in children with FD, higher BMI was linked to reduced GER and a lower MI, suggesting an association between increased BMI and gastric hypomotility. These findings underscore the importance of lifestyle and dietary interventions aimed at optimizing BMI in the management of FAPD, particularly FD. Further investigation is needed to unravel the causal mechanisms connecting BMI and gastric dysmotility in pediatric FGIDs. Such insights could pave the way for more tailored and effective treatment strategies.
We would like to acknowledge Mrs. Liyanayage JCD and Mrs. Ariyawansa J, Technical Officers, Department of Physiology, Faculty of Medicine, University of Kelaniya, Sri Lanka, for their assistance in gastric motility assessment and data collection.
1. | Korterink JJ, Diederen K, Benninga MA, Tabbers MM. Epidemiology of pediatric functional abdominal pain disorders: a meta-analysis. PLoS One. 2015;10:e0126982. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 240] [Cited by in RCA: 301] [Article Influence: 30.1] [Reference Citation Analysis (0)] |
2. | Sperber AD, Bangdiwala SI, Drossman DA, Ghoshal UC, Simren M, Tack J, Whitehead WE, Dumitrascu DL, Fang X, Fukudo S, Kellow J, Okeke E, Quigley EMM, Schmulson M, Whorwell P, Archampong T, Adibi P, Andresen V, Benninga MA, Bonaz B, Bor S, Fernandez LB, Choi SC, Corazziari ES, Francisconi C, Hani A, Lazebnik L, Lee YY, Mulak A, Rahman MM, Santos J, Setshedi M, Syam AF, Vanner S, Wong RK, Lopez-Colombo A, Costa V, Dickman R, Kanazawa M, Keshteli AH, Khatun R, Maleki I, Poitras P, Pratap N, Stefanyuk O, Thomson S, Zeevenhooven J, Palsson OS. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. Gastroenterology. 2021;160:99-114.e3. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 1325] [Cited by in RCA: 1148] [Article Influence: 287.0] [Reference Citation Analysis (0)] |
3. | Zhang X, Liu J, Ni Y, Yi C, Fang Y, Ning Q, Shen B, Zhang K, Liu Y, Yang L, Li K, Liu Y, Huang R, Li Z. Global Prevalence of Overweight and Obesity in Children and Adolescents: A Systematic Review and Meta-Analysis. JAMA Pediatr. 2024;178:800-813. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 19] [Cited by in RCA: 97] [Article Influence: 97.0] [Reference Citation Analysis (0)] |
4. | de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ. 2007;85:660-667. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 4196] [Cited by in RCA: 5340] [Article Influence: 314.1] [Reference Citation Analysis (0)] |
5. | Sathiadas MG, Antonyraja A, Viswalingam A, Thangaraja K, Wickramasinghe VP. Nutritional status of school children living in Northern part of Sri Lanka. BMC Pediatr. 2021;21:43. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 3] [Cited by in RCA: 8] [Article Influence: 2.0] [Reference Citation Analysis (0)] |
6. | Hyams JS, Di Lorenzo C, Saps M, Shulman RJ, Staiano A, van Tilburg M. Functional Disorders: Children and Adolescents. Gastroenterology. 2016;150:1456-1468. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 809] [Cited by in RCA: 791] [Article Influence: 87.9] [Reference Citation Analysis (4)] |
7. | Thapar N, Benninga MA, Crowell MD, Di Lorenzo C, Mack I, Nurko S, Saps M, Shulman RJ, Szajewska H, van Tilburg MAL, Enck P. Paediatric functional abdominal pain disorders. Nat Rev Dis Primers. 2020;6:89. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 48] [Cited by in RCA: 85] [Article Influence: 17.0] [Reference Citation Analysis (0)] |
8. | Devanarayana NM, Mettananda S, Liyanarachchi C, Nanayakkara N, Mendis N, Perera N, Rajindrajith S. Abdominal pain-predominant functional gastrointestinal diseases in children and adolescents: prevalence, symptomatology, and association with emotional stress. J Pediatr Gastroenterol Nutr. 2011;53:659-665. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 121] [Cited by in RCA: 107] [Article Influence: 7.6] [Reference Citation Analysis (0)] |
9. | Drossman DA. Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV. Gastroenterology. 2016;50:1262-1279. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 1366] [Cited by in RCA: 1362] [Article Influence: 151.3] [Reference Citation Analysis (1)] |
10. | Giorgio V, Margiotta G, Stella G, Di Cicco F, Leoni C, Proli F, Zampino G, Gasbarrini A, Onesimo R. Intestinal Permeability in Children with Functional Gastrointestinal Disorders: The Effects of Diet. Nutrients. 2022;14:1578. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 2] [Cited by in RCA: 8] [Article Influence: 2.7] [Reference Citation Analysis (0)] |
11. | Camilleri M. Disorders of gastrointestinal motility in neurologic diseases. Mayo Clin Proc. 1990;65:825-846. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 51] [Cited by in RCA: 43] [Article Influence: 1.2] [Reference Citation Analysis (0)] |
12. | Chumpitazi B, Nurko S. Pediatric gastrointestinal motility disorders: challenges and a clinical update. Gastroenterol Hepatol (N Y). 2008;4:140-148. [PubMed] |
13. | Stanghellini V, Tosetti C, Paternico A, Barbara G, Morselli-Labate AM, Monetti N, Marengo M, Corinaldesi R. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology. 1996;110:1036-1042. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 491] [Cited by in RCA: 452] [Article Influence: 15.6] [Reference Citation Analysis (0)] |
14. | Fischler B, Tack J, De Gucht V, Shkedy ZI, Persoons P, Broekaert D, Molenberghs G, Janssens J. Heterogeneity of symptom pattern, psychosocial factors, and pathophysiological mechanisms in severe functional dyspepsia. Gastroenterology. 2003;124:903-910. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 103] [Cited by in RCA: 101] [Article Influence: 4.6] [Reference Citation Analysis (0)] |
15. | Troncon LE, Bennett RJ, Ahluwalia NK, Thompson DG. Abnormal intragastric distribution of food during gastric emptying in functional dyspepsia patients. Gut. 1994;35:327-332. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 209] [Cited by in RCA: 225] [Article Influence: 7.3] [Reference Citation Analysis (0)] |
16. | Quigley EM. Review article: gastric emptying in functional gastrointestinal disorders. Aliment Pharmacol Ther. 2004;20 Suppl 7:56-60. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 47] [Cited by in RCA: 45] [Article Influence: 2.1] [Reference Citation Analysis (0)] |
17. | Quigley EM. Gastric and small intestinal motility in health and disease. Gastroenterol Clin North Am. 1996;25:113-145. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 74] [Cited by in RCA: 61] [Article Influence: 2.1] [Reference Citation Analysis (0)] |
18. | Thumshirn M. Pathophysiology of functional dyspepsia. Gut. 2002;51 Suppl 1:i63-i66. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 63] [Cited by in RCA: 55] [Article Influence: 2.4] [Reference Citation Analysis (0)] |
19. | Camilleri M. Abnormal gastrointestinal motility is a major factor in explaining symptoms and a potential therapeutic target in patients with disorders of gut-brain interaction. Gut. 2023;72:2372-2380. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 9] [Cited by in RCA: 16] [Article Influence: 8.0] [Reference Citation Analysis (0)] |
20. | Karunanayake A, Rajindrajith S, de Silva HA, Gunawardena S, Devanarayana NM. Autonomic functions and gastric motility in children with functional abdominal pain disorders. World J Gastroenterol. 2019;25:95-106. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in CrossRef: 12] [Cited by in RCA: 8] [Article Influence: 1.3] [Reference Citation Analysis (0)] |
21. | Devanarayana NM, Rajindrajith S, Bandara C, Shashiprabha G, Benninga MA. Ultrasonographic assessment of liquid gastric emptying and antral motility according to the subtypes of irritable bowel syndrome in children. J Pediatr Gastroenterol Nutr. 2013;56:443-448. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 37] [Cited by in RCA: 30] [Article Influence: 2.5] [Reference Citation Analysis (0)] |
22. | Devanarayana NM, Rajindrajith S, Rathnamalala N, Samaraweera S, Benninga MA. Delayed gastric emptying rates and impaired antral motility in children fulfilling Rome III criteria for functional abdominal pain. Neurogastroenterol Motil. 2012;24:420-425, e207. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 45] [Cited by in RCA: 39] [Article Influence: 3.0] [Reference Citation Analysis (0)] |
23. | Tack J, Piessevaux H, Coulie B, Caenepeel P, Janssens J. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology. 1998;115:1346-1352. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 771] [Cited by in RCA: 759] [Article Influence: 28.1] [Reference Citation Analysis (0)] |
24. | Ganesh M, Nurko S. Functional dyspepsia in children. Pediatr Ann. 2014;43:e101-e105. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 15] [Cited by in RCA: 17] [Article Influence: 1.5] [Reference Citation Analysis (0)] |
25. | Chey WY, Jin HO, Lee MH, Sun SW, Lee KY. Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea. Am J Gastroenterol. 2001;96:1499-1506. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 227] [Cited by in RCA: 243] [Article Influence: 10.1] [Reference Citation Analysis (0)] |
26. | Phatak UP, Pashankar DS. Prevalence of functional gastrointestinal disorders in obese and overweight children. Int J Obes (Lond). 2014;38:1324-1327. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 41] [Cited by in RCA: 49] [Article Influence: 4.5] [Reference Citation Analysis (0)] |
27. | Nurko S. The tip of the iceberg: the prevalence of functional gastrointestinal diseases in children. J Pediatr. 2009;154:313-315. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 11] [Cited by in RCA: 10] [Article Influence: 0.6] [Reference Citation Analysis (0)] |
28. | Bonilla S, Wang D, Saps M. Obesity predicts persistence of pain in children with functional gastrointestinal disorders. Int J Obes (Lond). 2011;35:517-521. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 16] [Cited by in RCA: 21] [Article Influence: 1.4] [Reference Citation Analysis (0)] |
29. | Camilleri M, Papathanasopoulos A, Odunsi ST. Actions and therapeutic pathways of ghrelin for gastrointestinal disorders. Nat Rev Gastroenterol Hepatol. 2009;6:343-352. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 99] [Cited by in RCA: 86] [Article Influence: 5.4] [Reference Citation Analysis (0)] |
30. | Miron I, Dumitrascu DL. Gastrointestinal motility disorders in obesity. Acta Endocrinol (Buchar). 2019;15:497-504. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 27] [Cited by in RCA: 20] [Article Influence: 3.3] [Reference Citation Analysis (0)] |
31. | Camilleri M. Cannabinoids and gastrointestinal motility: Pharmacology, clinical effects, and potential therapeutics in humans. Neurogastroenterol Motil. 2018;30:e13370. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 50] [Cited by in RCA: 63] [Article Influence: 9.0] [Reference Citation Analysis (0)] |
32. | Shi YC, Baldock PA. Central and peripheral mechanisms of the NPY system in the regulation of bone and adipose tissue. Bone. 2012;50:430-436. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 58] [Cited by in RCA: 63] [Article Influence: 4.8] [Reference Citation Analysis (0)] |
33. | Camilleri M, Bueno L, Andresen V, De Ponti F, Choi MG, Lembo A. Pharmacological, Pharmacokinetic, and Pharmacogenomic Aspects of Functional Gastrointestinal Disorders. Gastroenterology. 2016;150:1319-1331. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 23] [Cited by in RCA: 24] [Article Influence: 2.7] [Reference Citation Analysis (0)] |
34. | Kusunoki H, Haruma K, Hata J, Tani H, Okamoto E, Sumii K, Kajiyama G. Real-time ultrasonographic assessment of antroduodenal motility after ingestion of solid and liquid meals by patients with functional dyspepsia. J Gastroenterol Hepatol. 2000;15:1022-1027. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 62] [Cited by in RCA: 56] [Article Influence: 2.2] [Reference Citation Analysis (0)] |
35. | Camilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L; American College of Gastroenterology. Clinical guideline: management of gastroparesis. Am J Gastroenterol. 2013;108:18-37; quiz 38. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 824] [Cited by in RCA: 742] [Article Influence: 61.8] [Reference Citation Analysis (1)] |
36. | Lee KJ, Kindt S, Tack J. Pathophysiology of functional dyspepsia. Best Pract Res Clin Gastroenterol. 2004;18:707-716. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 45] [Cited by in RCA: 48] [Article Influence: 2.3] [Reference Citation Analysis (0)] |
37. | Tack J, Lee KJ. Pathophysiology and treatment of functional dyspepsia. J Clin Gastroenterol. 2005;39:S211-S216. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 77] [Cited by in RCA: 75] [Article Influence: 3.8] [Reference Citation Analysis (0)] |
38. | Papadopoulos GE, Balomenou F, Sakellariou XM, Tassopoulos C, Nikas DN, Giapros V, Kolettis TM. Autonomic Function in Obese Children and Adolescents: Systematic Review and Meta-Analysis. J Clin Med. 2024;13:1854. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 3] [Reference Citation Analysis (0)] |
39. | Park DI, Rhee PL, Kim YH, Sung IK, Son HJ, Kim JJ, Paik SW, Rhee JC, Choi KW. Role of autonomic dysfunction in patients with functional dyspepsia. Dig Liver Dis. 2001;33:464-471. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 16] [Cited by in RCA: 18] [Article Influence: 0.8] [Reference Citation Analysis (0)] |
40. | Guo WJ, Yao SK, Zhang YL, Du SY, Wang HF, Yin LJ, Li HL. Impaired vagal activity to meal in patients with functional dyspepsia and delayed gastric emptying. J Int Med Res. 2018;46:792-801. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 16] [Cited by in RCA: 19] [Article Influence: 2.7] [Reference Citation Analysis (0)] |
41. | Cifuentes L, Camilleri M, Acosta A. Gastric Sensory and Motor Functions and Energy Intake in Health and Obesity-Therapeutic Implications. Nutrients. 2021;13:1158. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 9] [Cited by in RCA: 34] [Article Influence: 8.5] [Reference Citation Analysis (0)] |
42. | Keohane J, Quigley EM. Functional dyspepsia: the role of visceral hypersensitivity in its pathogenesis. World J Gastroenterol. 2006;12:2672-2676. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in CrossRef: 23] [Cited by in RCA: 28] [Article Influence: 1.5] [Reference Citation Analysis (0)] |